Department of Pharmacy, St Antoine Hospital, AP-HP Sorbonne Université, Paris, France
Université de Paris, PARCC, INSERM, F-75015 Paris, France, Paris, France.
BMJ Open. 2021 Dec 2;11(12):e049632. doi: 10.1136/bmjopen-2021-049632.
In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce.Here, we describe antihypertensive drug strategies and identify treatment factors associated with blood pressure (BP) control in 12 Sub-Saharan countries.
Outpatient consultations for hypertension in urban tertiary cardiology centres of 29 hospitals from 17 cities across 12 SSA countries between January 2014 and November 2015.
Patients ≥18 years of age with hypertension were enrolled at any visit during outpatient consultations in the cardiology departments MAIN OUTCOME MEASURE: We collected BP levels, demographic characteristics and antihypertensive treatment use (including traditional medicine) of patients with hypertension attending outpatient visits. BP control was defined as seated office BP <140/90 mm Hg. We used logistic regression with a random effect on countries to assess factors of BP control.
Overall, 2198 hypertensive patients were included and a total of 96.6% (n=2123) were on antihypertensive medications. Among treated patients, 653 (30.8%) patients received a monotherapy by calcium channel blocker (n=324, 49.6%), renin-angiotensin system blocker (RAS) (n=126, 19.3%) or diuretic (n=122, 18.7%). Two-drug strategies were prescribed in 927 (43.6%) patients including mainly diuretics and RAS (n=327, 42% of two-drug strategies). Prescriptions of three-drugs or more were used in 543 (25.6%) patients. Overall, among treated patients, 1630 (76.7%) had uncontrolled BP, of whom 462 (28.3%) had BP levels ≥180/110 mm Hg, mainly in those on monotherapy. After adjustment for sociodemographic factors, the use of traditional medicine was the only factor significantly associated with uncontrolled BP (OR 1.72 (1.19 to 2.49) p<0.01).
Our study provided large-scale data on antihypertensive prescriptions in the African continent. Among patients declared adherent to drugs, poor BP control was significantly associated with the use of traditional medicine.
在非洲,预计到 2030 年高血压患者人数将达到 2.168 亿。撒哈拉以南非洲(SSA)大规模使用抗高血压药物的数据稀缺。在这里,我们描述了抗高血压药物策略,并确定了与 12 个撒哈拉以南国家血压控制相关的治疗因素。
2014 年 1 月至 2015 年 11 月,在 17 个城市的 29 家医院的城市三级心脏病学中心进行的高血压门诊咨询中,对年龄≥18 岁的高血压患者进行了登记。
在心脏病科门诊就诊的高血压患者,无论何时就诊均可参加。
我们收集了参加门诊的高血压患者的血压水平、人口统计学特征和抗高血压药物(包括传统医学)的使用情况。坐位办公室血压<140/90 mmHg 定义为血压控制。我们使用基于国家的随机效应逻辑回归评估血压控制的因素。
共有 2198 名高血压患者被纳入研究,共有 96.6%(n=2123)接受抗高血压药物治疗。在接受治疗的患者中,653(30.8%)名患者接受钙通道阻滞剂(n=324,49.6%)、肾素-血管紧张素系统阻滞剂(RAS)(n=126,19.3%)或利尿剂(n=122,18.7%)单一药物治疗。927 名(43.6%)患者采用了二药治疗策略,主要包括利尿剂和 RAS(n=327,二药治疗策略的 42%)。543 名(25.6%)患者使用了三种或更多药物的治疗方案。总体而言,在接受治疗的患者中,1630 名(76.7%)血压控制不佳,其中 462 名(28.3%)血压水平≥180/110 mmHg,主要见于单一药物治疗患者。调整社会人口因素后,使用传统医学是唯一与血压控制不佳显著相关的因素(比值比 1.72(1.19 至 2.49),p<0.01)。
本研究提供了非洲大陆抗高血压药物处方的大规模数据。在报告遵医嘱服药的患者中,血压控制不佳与使用传统医学显著相关。